- Ownership hops held
- 71
An absent edge means not yet observed — never does not exist.
Taysha Gene Therapies, Inc.
Taysha Gene Therapies, Inc. — US company (sec:0001806310). UBO chain traced 71 hops, 4 owners. Every claim linked to its source.
Ownership resolves 71 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- Taysha Gene Therapies, Inc.
None in current sources.
71-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.
Everything we hold on Taysha Gene Therapies, Inc., resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €149.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBOSTANDARD
- Full export (PDF + un-redacted JSON) & change alertsPREMIUM
People & control
12 parties · 0 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- ASTELLAS PHARMA INC.Also holds roles at 5 other companies
- FIBROGEN INCother
- FIBROGEN INCtenpercentowner
- ONCOGENE SCIENCE INCtenpercentowner
- AUDENTES THERAPEUTICS, INC.Also holds roles at 49 other companies
- MORRISON SCOTT Wdirector
- LANGE LOUIS Gdirector
- GOLDBERG MARK ALANdirector
- DONENBERG PHILIP BAlso holds roles at 7 other companies
- ANI PHARMACEUTICALS INCofficer
- Sensei Biotherapeutics, Inc.director
- Tectonic Therapeutic, Inc.director
- MANNING PAUL BAlso holds roles at 14 other companies
- Liquidia Corpdirector
- Candel Therapeutics, Inc.director
- Verrica Pharmaceuticals Inc.tenpercentowner
- Nagendran SukumarAlso holds roles at 3 other companies
- Solid Biosciences Inc.director
- Immunovant, Inc.director
- AVEXIS, INC.officer
- Nolan Sean P.Also holds roles at 6 other companies
- Ventas, Inc.director
- SOCIAL CAPITAL SUVRETTA HOLDINGS CORP. IIdirector
- Neurogene Inc.director
- Sepp-Lorenzino LauraAlso holds roles at 2 other companies
- Intellia Therapeutics, Inc.officer
- Lexeo Therapeutics, Inc.director
- SESSION R.A. IIAlso holds roles at 2 other companies
- CHARDAN HEALTHCARE ACQUISITION 2 CORP.director
- AVEXIS, INC.officer
- STALFORT JOHN A IIIAlso holds roles at 3 other companies
- Acumen Pharmaceuticals, Inc.director
- Verrica Pharmaceuticals Inc.director
- DOVA PHARMACEUTICALS INC.director
12 parties · 0 current. Ceased and resigned records are retained as history.
Common questions
- Who owns Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc.'s risk level?
- Where does Taysha Gene Therapies, Inc. appear across sources?